Literature DB >> 9493516

Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence.

H Verbaan1, A Widell, L Bondeson, K Andersson, S Eriksson.   

Abstract

The aim of this study was to evaluate the importance of different endogenous and exogenous factors associated with cirrhosis development among hepatitis C virus (HCV)-positive individuals from an area of low prevalence. We studied 106 consecutive HCV RNA positive patients who had undergone liver biopsy. Each patient was assessed with special attention to risk factors for hepatitis C infection, average daily alcohol consumption and analysis of plasma levels of alpha1-antitrypsin (alpha1AT) and alpha1-antichymotrypsin (alpha1ACT). Viral RNA, amplified from serum with the polymerase chain reaction (PCR) technique, was used for genotyping. Liver biopsies were assessed according to conventional histopathological criteria, and for necroinflammatory activity (grade) and fibrosis (stage) according to a numerical scoring system. The presence of cirrhosis (stage 4) was used as the dependent variable in multivariate logistic regression analysis. Alcohol abuse (P = 0.007), age at entry (P < 0.001), immigrant status (P = 0.017) and a low alpha1ACT level (P = 0.008) were all independent determinants of progression to cirrhosis whereas HCV genotype 1, estimated duration of HCV infection and positivity for antibodies to hepatitis B core antigen (HBcAb) were not. Cirrhosis occurred at a significantly younger age (P = 0.00(5) among alcohol abusers. Hence, both endogenous and exogenous factors such as subnormal alpha1ACT levels and alcohol appear to contribute to the rate of progression to cirrhosis among HCV-positive patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493516     DOI: 10.1046/j.1365-2893.1998.00082.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  5 in total

1.  Role of alpha-1-antichymotrypsin deficiency in promoting cirrhosis in two siblings with heterozygous alpha-1-antitrypsin deficiency phenotype SZ.

Authors:  D Yoon; F Kueppers; R M Genta; G B Klintmalm; V I Khaoustov; B Yoffe
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 2.  Role of occult hepatitis B virus infection in chronic hepatitis C.

Authors:  Nicola Coppola; Lorenzo Onorato; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Salvatore Martini; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients.

Authors:  Liliana S C Mendes; Marcelo E Nita; Suzane K Ono-Nita; Evandro S Mello; Luiz Caetano da Silva; Venancio A F Alves; Flair J Carrilho
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

4.  Occult HBV infection status and its impact on surgical outcomes in patients with curative resection for HCV-associated hepatocellular carcinoma.

Authors:  Koutaro Yamaji; Keita Kai; Sho Komukai; Hiroki Koga; Takao Ide; Atsushi Kawaguchi; Hirokazu Noshiro; Shinichi Aishima
Journal:  Hepatobiliary Surg Nutr       Date:  2018-12       Impact factor: 7.293

5.  Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review.

Authors:  Laura Llamosas-Falcón; Kevin D Shield; Maya Gelovany; Jakob Manthey; Jürgen Rehm
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.